Companion Cat Hyperthyroidism Advanced Management

Feline hyperthyroidism is the most common endocrine disease in older cats; welfare outcomes depend on selecting the optimal treatment for individual circumstances.

Key Facts

Feline hyperthyroidism affects approximately 10% of cats over 10 years old
It is caused by benign adenomatous hyperplasia of thyroid tissue in the majority of cases
Clinical signs include weight loss despite increased appetite, hyperactivity and vomiting
Four treatment options exist: daily medication, radioactive iodine therapy, surgery, or dietary iodine restriction
Radioactive iodine (I-131) is curative in over 95% of cases with a single treatment
Methimazole and carbimazole require daily administration and regular monitoring
Uncontrolled hyperthyroidism causes cardiac hypertrophy and hypertension requiring concurrent management
Underlying kidney disease is often unmasked when hyperthyroidism is treated

Welfare Considerations

Untreated feline hyperthyroidism causes progressive deterioration through weight loss, muscle wasting, cardiac disease and hypertension. The welfare significance increases as the disease progresses. Treatment dramatically improves quality of life for affected cats. Treatment selection must consider the cat's temperament, owner circumstances and concurrent health conditions. Radioactive iodine provides the most durable welfare outcome but requires a period of hospitalisation. The unmasking of renal disease after treatment requires careful management to optimise overall welfare.

What You Can Do

Schedule veterinary assessment promptly for older cats showing unexplained weight loss
Discuss all treatment options with your vet and consider radioactive iodine if available
Commit to regular monitoring if using daily medication - blood tests every 3-6 months are essential
Manage concurrent cardiac and renal disease alongside hyperthyroidism treatment
Ensure iodine-restricted diets are fed exclusively - any supplementary food negates the restriction